Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclease EXOG, mitochondrial (EXOG) is a dimeric mitochondrial enzyme in humans that functions with both 5′–3′ exonuclease and endonuclease activity, with a preference for single-stranded DNA but can also nick supercoiled DNA. It is essential for mitochondrial DNA repair, including removal of RNA primers during DNA replication and repair of mtDNA, and may play roles in programmed cell death and normal cell proliferation. EXOG is encoded by a nuclear gene but localizes to the inner mitochondrial membrane through a hydrophobic N-terminal transmembrane segment. It complements the related Endonuclease G (EndoG), which in mammals is a pure endonuclease; together these two enzymes likely cover all major mitochondrial nucleic acid metabolism functions in higher eukaryotes. SNPs in or near the EXOG gene have been associated with risk for certain diseases, such as type II diabetes, emphasizing its importance in mitochondrial integrity and cellular health. No drugs or clinical inhibitors specifically target EXOG according to current evidence.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclease EXOG, mitochondrial (EXOG).